Skip to Content

A33 (Oxybutynin chloride extended-release 15 mg)

Pill imprint A33 has been identified as Oxybutynin chloride extended-release 15 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; prostatitis; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Oxybutynin chloride extended-release 15 mg A33
Oxybutynin chloride extended-release 15 mg A33
Discount Card Promo
Oxybutynin chloride extended-release
Imprint:
A33
Strength:
15 mg
Color:
White
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Amneal Pharmaceuticals of New York, LLC

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide